SCHEMBL13634389

SCHEMBL13634389

CCc1ccc(N2CCOCC2)cc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.52
KMT2A Q03164 6/20 0.52
THRB P10828 2/20 0.52
ALDH1A1 P00352 8/20 0.52
HPGD P15428 3/20 0.52
POLB P06746 1/20 0.52
MAPT P10636 9/20 0.51
NPSR1 Q6W5P4 1/20 0.51
GAA P10253 3/20 0.50
HIF1A Q16665 2/20 0.50
KDM4E B2RXH2 2/20 0.49
HTT P42858 1/20 0.49
PKM P14618 1/20 0.48
CYP3A4 P08684 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
HSD17B10 Q99714 1/20 0.47
P2RX7 Q99572 1/20 0.46
INSR P06213 1/20 0.46
ALK Q9UM73 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20467557 0.87 TTK (0.47) MEN1KMT2ATHRBALDH1A1HPGD
SCHEMBL12806687 0.86 ALDH1A1 (0.60) MEN1KMT2AALDH1A1MAPTNPSR1
SCHEMBL20354532 0.85 MEN1 (0.50) MEN1KMT2ATHRBALDH1A1HPGD
SCHEMBL21566486 0.83 SIRT6 (0.59) ALDH1A1POLBKDM4ENPC1RAB9A
SCHEMBL19500869 0.82 HIF1A (0.62) MEN1KMT2ATHRBALDH1A1HPGD
SCHEMBL13634954 0.81 ALDH1A1 (0.48) ALDH1A1MAPTGAAKDM4EHTT
SCHEMBL14035870 0.80 MAPT (0.54) MEN1KMT2AALDH1A1HPGDPOLB
SCHEMBL1911848 0.80 MEN1 (0.56) MEN1KMT2ATHRBALDH1A1HPGD
SCHEMBL12141732 0.79 DPP4 (0.48) ALDH1A1MAPT
SCHEMBL24155068 0.79 HIF1A (0.60) MEN1KMT2ATHRBALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090291945-A1 CYSTEINE PROTEASE INHIBITORS TEIJIN PHARMA LIMITED (JP) 2009-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090291945-A1 CYSTEINE PROTEASE INHIBITORS CTSE, SPINT2, CTSF MEN1 1994/4885KMT2A 3986/4885THRB 3702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.